Amylyx Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Amylyx Pharmaceuticals (AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
March 30, 2022 4:51 PM EDT(Updated - March 30, 2022 4:51 PM EDT)
Amylyx Pharmaceuticals (NASDAQ: AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
... MoreAmylyx Pharmaceuticals (AMLX) Confirms Shares Halted Ahead of FDA Advisory Committee Meeting to Discuss NDA for AMX0035 for the Treatment of ALS
March 30, 2022 7:07 AM EDTAmylyx Pharmaceuticals (NASDAQ: AMLX) today announced that Nasdaq has halted trading of the companys common stock.
The U.S. Food and Drug Administrations (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) is meeting today to review the New Drug Application... More



